secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001193125-24-003489
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharmaceuticals prices public offering of 10M shares at $15.00, raising $150M gross
--------------------------------------------------------------------------------

- Offering of 10,000,000 shares at $15.00 each, gross proceeds $150M; net proceeds ~$140.1M.
- Underwriters have 30-day option to purchase up to an additional 1.5M shares.
- Net proceeds to fund potential acquisition of new product candidates and general corporate purposes.
- Offering expected to close on January 9, 2024; underwriters include BofA Securities and Citigroup.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312524003489/0001193125-24-003489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312524003489/d149661d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer